Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder

NIH [6/13] | NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people. Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Cont.